Navigation Links
Fox Chase Cancer Center leads efforts to establish national standards for survivorship care
Date:3/19/2012

HOLLYWOOD, Fla. (March 18, 2012)People are living longer with and after a cancer diagnosis, making survivorship clinics and programsas well as official guidelines and practices governing the care of survivorsan important emerging component of modern cancer care. Many institutions are looking to gather these resources into an easily understandable plan for their survivors.

"Cancer survivors face a lot of unique and very specific challenges," says Crystal S. Denlinger, M.D., a medical oncologist at Fox Chase Cancer Center who will present on best practices in cancer survivorship at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care on March 18. "In oncology medicine, there has been a much more concerted effort to address these needs in a systematic way."

Denlinger has been leading efforts for the last five years to enhance survivorship care at Fox Chasea founding member of the National Comprehensive Cancer Network (NCCN) and a national leader in the movement towards better survivorship care. She spearheaded the development of the Center for Survivorship at Fox Chase, which collects in-house and by-referral resources to provide comprehensive survivorship care to the Center's patient population.

At the presentation, Denlinger and her colleagues will address best practices and the major elements of survivorship care. They will cite the most current research on survivorship, which includes recently released guidelines from the American Cancer Society on nutrition and physical activity and the American College of Sports Medicine on exercise. The goal of such guidelines is to shepherd the survivor through the four "seasons of survival," which include acute, transitional, extended and permanent survivorshipor the path from diagnosis to remission and beyond.

Denlinger notes that even patients with metastatic disease have unique survivorship care needs.

"Some people are considered cured after treatment and others will continue to live with their cancer," she says. "Just because you're living with cancer doesn't mean you're not a survivor. We need to address the unique needs of both populations."

Denlinger is currently working to develop Fox Chase's own survivorship care plan, which will be a printed packet that is tailored to each patient, summarizing therapy and making recommendations based on the patient's specific case. She will also be working with other members of the NCCN network over the next year to establish a full panel on cancer survivorship in time for next year's conference.

"Fox Chase's efforts in this area will continue to evolve as awareness about survivors' needs increases and we continue to focus more on life with and after cancer," Denlinger says.

Cancer accreditation organizations are increasing their focus on survivorship as well, Denlinger says, and may soon include survivorship care plans in their requirements.

Denlinger will be joined at the NCCN discussion by Terry S. Langbaum, M.A.S., from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, who will discuss survivorship from the survivor perspective, and Mary S. McCabe, R.N., M.A., of Memorial Sloan-Kettering Cancer Center, who will address the importance of the survivorship care plan.


'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. Psychologists chase down sleep demons
2. Fox Chase researchers improve accuracy of IMRT delivery in post-prostatectomy patients
3. Fox Chase Gleason scores better predict prostate cancers recurrence after radiation
4. Fox Chase researchers identifiy more accurate treatment delivery for robotic radiosurgery system
5. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
6. Fox Chase Cancer Center signs agreement with Life Technologies Corp.
7. Study: Lowering cost doesnt increase hearing aid purchases
8. Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen
9. Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
10. Fox Chase scientists report interplay between cancer and aging in mice
11. Fox Chase researchers develop a screen for identifying new anticancer drug targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... SPH ... firms. The ranking is based on reported data for 2015 performance and ... systems, ambulatory surgical centers, clinically integrated networks, and many of the nation’s leading ...
(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... ... December 06, 2016 , ... Just in time for the holiday season, ... chip cookie recipe for Honeyville’s new Organic Quinoa Flour product for sale at Costco ... the near future. , “I think it’s wonderful that a growing number of ...
(Date:12/6/2016)... ... ... Keeping Gift Season Safe, In a season stacked with gift-giving opportunities, it's ... recipients. This is the idea behind Safe Toys and Gifts Month, which sets aside ... good gifts for children. For companies that produce goods that fall into this category, ...
(Date:12/6/2016)... Viejo, California (PRWEB) , ... December 06, 2016 , ... ... allows users to flicker, flash, and flare from clip to clip with high quality ... , TransFlare 4K Jewel contains 44 lens flares filmed on the RED Dragon. ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
(Date:12/5/2016)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ... an enhanced technology platform designed with the ability to ... Pyxis™ and Alaris™ systems, at this year,s American ... being held in Las Vegas ... that approximately 68 percent of medication errors occur during ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology: